Leisure Capital Management Adamis Pharmaceuticals Corp Transaction History

Leisure Capital Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$0.7 - $1.46 $15,617 - $32,574	-22,311 Closed	0 $0
Q2 2019 Jul 10, 2019	SELL	$1.26 - $2.23 $117,700 - $208,310	-93,413 Reduced 80.72%	22,311 $29,000
Q1 2019 May 08, 2019	BUY	$2.02 - $3.22 $10,033 - $15,993	4,967 Added 4.48%	115,724 $244,000
Q4 2018 Feb 13, 2019	SELL	$2.1 - $3.21 $21,384 - $32,687	-10,183 Reduced 8.42%	110,757 $249,000
Q3 2018 Nov 09, 2018	SELL	$2.25 - $4.8 $81,812 - $174,532	-36,361 Reduced 23.12%	120,940 $423,000
Q2 2018 Aug 02, 2018	BUY	$3.2 - $4.7 $42,803 - $62,867	13,376 Added 9.29%	157,301 $503,000
Q1 2018 May 11, 2018	SELL	$2.55 - $4.85 $6,772 - $12,881	-2,656 Reduced 1.81%	143,925 $504,000
Q4 2017 Feb 12, 2018	BUY	$3.5 - $5.65 $11,214 - $18,102	3,204 Added 2.23%	146,581 $645,000
Q3 2017 Oct 24, 2017	SELL	$4.5 - $5.65 $11,394 - $14,305	-2,532 Reduced 1.74%	143,377 $749,000
Q2 2017 Aug 09, 2017	BUY	N/A	145,909	145,909 $759,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Leisure Capital Management, based on Form 13F filings with the SEC.

Stay updated on Leisure Capital Management with notifications on news.